CN112336756A - Preparation method of acer truncatum leaf tea granules - Google Patents

Preparation method of acer truncatum leaf tea granules Download PDF

Info

Publication number
CN112336756A
CN112336756A CN201910727611.9A CN201910727611A CN112336756A CN 112336756 A CN112336756 A CN 112336756A CN 201910727611 A CN201910727611 A CN 201910727611A CN 112336756 A CN112336756 A CN 112336756A
Authority
CN
China
Prior art keywords
acer truncatum
preparation
leaf tea
extract
putting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201910727611.9A
Other languages
Chinese (zh)
Inventor
周兵
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shenzhen Jinfeng Biomedical Technology Co ltd
Original Assignee
Shenzhen Jinfeng Biomedical Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shenzhen Jinfeng Biomedical Technology Co ltd filed Critical Shenzhen Jinfeng Biomedical Technology Co ltd
Priority to CN201910727611.9A priority Critical patent/CN112336756A/en
Priority to PCT/CN2020/080048 priority patent/WO2021022813A1/en
Publication of CN112336756A publication Critical patent/CN112336756A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/20Aceraceae (Maple family)
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23FCOFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F3/00Tea; Tea substitutes; Preparations thereof
    • A23F3/34Tea substitutes, e.g. matè; Extracts or infusions thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10Laxatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/39Complex extraction schemes, e.g. fractionation or repeated extraction steps

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Anesthesiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a preparation method of acer truncatum leaf tea granules, which comprises the following steps: s1, preparing raw materials of acer truncatum leaves, a cosolvent, a flavoring agent and a sweetening agent; s2, putting the acer truncatum leaves into an extraction tank, adding water, heating and decocting, and filtering repeatedly for three times to obtain filtrate; s3, pumping the filtrate into a concentration tank through a liquid pump, and concentrating to obtain an extract; s4, adding auxiliary materials into the extract, and stirring and uniformly mixing in a stirrer; s5, putting the mixture into a dryer, and drying to obtain dry paste powder; s6, putting the dry paste powder into a grinder for grinding, and screening by a vibrating screen; s7, packaging the screened dry paste powder with a medicinal composite film, and bagging to obtain a finished product, which relates to the technical field of traditional Chinese medicine products. The prepared electuary can realize full-ingredient extraction, production science and quality control, and large-scale production can be realized; the granule is convenient for administration, hygiene and storage.

Description

Preparation method of acer truncatum leaf tea granules
Technical Field
The invention relates to the technical field of traditional Chinese medicine products, in particular to a preparation method of acer truncatum leaf tea granules.
Background
Acer truncatum, a plant of the genus Acer of the family Aceraceae, is named because the wing fruit is shaped like the gold ingot of ancient China. In the 70 th century of 20 th century, the original professor of the agricultural academy of northwest kingdom of Wang Yang (King's disease) used the acer truncatum seeds for the first time to squeeze edible oil to relieve the tension of edible oil in China, and until 2005, the professor of Wang Yang (Sedum truncatum), discovered that the acer truncatum seeds contain up to 5.2% of nervonic acid, created a new era in brain science history, and discovered that the leaves and seed coats of the acer truncatum also contain a large amount of beneficial bioactive substances through more intensive research. Under the promotion of the scientific research results of the professor of the Wang sex inflammation, a large number of scholars research the acer truncatum from different aspects, such as cultivation and breeding, the content of bioactive substances of each part of the acer truncatum, extraction processes and the like. With the continuous development of the acer truncatum industry, the development and application research of acer truncatum is only carried out on acer truncatum seed oil, and many researchers research the components of acer truncatum leaf active substances, and find that acer truncatum leaves contain various bioactive components such as flavonoids, chlorogenic acid, polysaccharides, vitamins, amino acids, superoxide dismutase (SOD) and the like, wherein the contents of chlorogenic acid and flavonoids are high, and a large amount of research provides a basis for mastering the dynamic content rule of the acer truncatum leaves and the extraction, application and development of the acer truncatum leaves active substances, and provides guidance for accurately and efficiently obtaining and efficiently developing and applying the active components in the acer truncatum leaves in the acer truncatum industry.
Research shows that the acer truncatum bunge leaf has the effects of reducing three highs (hyperglycemia, hyperlipidemia and hypertension), losing weight, helping sleep, resisting oxidation and viruses, enhancing the action of stomach power and the like. Therefore, compared with green tea, the acer truncatum leaf tea is good tea with a health care effect, and has a good development prospect. At present, the acer truncatum leaves are mainly drunk in the form of tea infusion, the decoction quality is difficult to guarantee, the taking is inconvenient, and the storage is difficult. The granule is a product obtained by extracting, concentrating and granulating by modern high and new technology, and ensures the property and taste characteristics of the original raw materials.
Disclosure of Invention
The invention aims to make up the defects of the prior art and provides a preparation method of acer truncatum leaf tea granules, which comprises the following steps:
s1, preparing raw materials of acer truncatum leaves, a cosolvent, a flavoring agent and a sweetening agent;
s2, putting the acer truncatum leaves into an extraction tank, adding water, heating and decocting, and filtering repeatedly for three times to obtain filtrate;
s3, pumping the filtrate into a concentration tank through a liquid pump, and concentrating to obtain an extract;
s4, adding auxiliary materials into the extract, and stirring and uniformly mixing in a stirrer;
s5, putting the mixture into a dryer, and drying to obtain dry paste powder;
s6, putting the dry paste powder into a grinder for grinding, and screening by a vibrating screen;
s7, packaging the screened dry paste powder with a medicinal composite film, and bagging to obtain the finished product.
Preferably, in the S2, water is added, the water is 5-40 times of the acer truncatum leaves, the mixture is heated and decocted for 0.5-5 hours, then the water is added, the mixture is heated and decocted for 0.5-5 hours, and then the water is added, and the mixture is heated and decocted for 0.5-5 hours.
Preferably, in the S3 step, the extract is concentrated to a relative density of 1.00-1.20.
Preferably, in the S4, the auxiliary materials are cosolvent, flavoring agent or sweetener, and the adding amount is 0.05-200%, 0-5% and 0-10% of the extract.
Preferably, the cosolvent comprises one or more of sodium benzoate, citric acid, calcium lactate, maltodextrin, soluble starch and tween 80; the flavoring agent comprises one or more of peppermint oil, essence and beta-cyclodextrin; the sweetener comprises one or more of stevioside, sucrose, honey, fructose, glycyrrhizin, aspartame and saccharin sodium.
Preferably, in the step S5, the temperature of the dryer is 40-100 ℃, and the drying time is 20-100 min.
Preferably, in the S6, the size of the vibrating screen is 80-120 meshes.
Compared with the prior art, the invention has the following beneficial effects: the granule prepared by the invention can realize the extraction of all components, the production science and the quality are controllable, and the large-scale production can be realized; the electuary prepared by the invention is convenient to take, sanitary and convenient to store; the acer truncatum leaf tea granules can effectively shorten the sleep latency of animals, prolong the sleep time and have the effect of promoting sleep; the granule prepared by the invention has the health-care functions of obviously reducing blood fat, blood pressure and blood sugar.
Drawings
The invention is described in further detail below with reference to the following figures and detailed description:
fig. 1 is a schematic view of the present invention as a whole.
Detailed Description
The following description of the embodiments of the present invention is provided for illustrative purposes, and other advantages and effects of the present invention will become apparent to those skilled in the art from the present disclosure.
Please refer to fig. 1. It should be understood that the structures, ratios, sizes, and the like shown in the drawings and described in the specification are only used for matching with the disclosure of the specification, so as to be understood and read by those skilled in the art, and are not used to limit the conditions under which the present invention can be implemented, so that the present invention has no technical significance, and any structural modification, ratio relationship change, or size adjustment should still fall within the scope of the present invention without affecting the efficacy and the achievable purpose of the present invention. In addition, the terms "upper", "lower", "left", "right", "middle" and "one" used in the present specification are for clarity of description, and are not intended to limit the scope of the present invention, and the relative relationship between the terms and the terms is not to be construed as a scope of the present invention.
Example 1: a preparation method of acer truncatum leaf tea granules comprises the following steps:
s1, preparing raw materials of acer truncatum leaves, a cosolvent, a flavoring agent and a sweetening agent;
s2, putting the acer truncatum leaves into an extraction tank, adding water, heating and decocting, and filtering repeatedly for three times to obtain filtrate;
s3, pumping the filtrate into a concentration tank through a liquid pump, and concentrating to obtain 390g of extract;
s4, adding auxiliary materials into the extract, and stirring and uniformly mixing in a stirrer;
s5, putting the mixture into a dryer, and drying to obtain dry paste powder;
s6, putting the dry paste powder into a grinder for grinding, and screening by a vibrating screen;
s7, packaging the screened dry paste powder with a medicinal composite film, and bagging to obtain the finished product.
In the step S2, 1kg of acer truncatum leaves is added with 10L of water, heated and decocted for 1 hour, and the process is repeated for three times.
And in the S3, concentrating the extract until the relative density is 1.07.
And in the step S4, auxiliary materials including maltodextrin, cyclodextrin and stevioside are added, wherein the addition amount of the auxiliary materials is 1%, 1.1% and 2% of the extract.
And in the step S5, the temperature of the dryer is 70 ℃, and the drying time is 30 min.
In the S6, the specification of the vibrating screen is 80 meshes.
Example 2: taking 50g of the acer truncatum leaf extract of the example 1, adding 50g of maltodextrin, 1g of beta-cyclodextrin, 0.5g of stevioside and 500ml of water, stirring for dissolving, and drying in vacuum to obtain a product.
Example 3: taking 50g of the acer truncatum leaf extract of the example 1, adding 50g of soluble starch, 0.5g of beta-cyclodextrin, 1g of cane sugar and 300ml of water, stirring for dissolving, and drying in vacuum to obtain a product.
Example 4: a preparation method of acer truncatum leaf tea granules comprises the following steps:
s1, preparing raw materials of acer truncatum leaves, a cosolvent, a flavoring agent and a sweetening agent;
s2, putting the acer truncatum leaves into an extraction tank, adding water, heating and decocting, and filtering repeatedly for three times to obtain filtrate;
s3, pumping the filtrate into a concentration tank through a liquid pump, and concentrating to obtain an extract;
s4, adding auxiliary materials into the extract, and stirring and uniformly mixing in a stirrer;
s5, putting the mixture into a dryer, and drying to obtain dry paste powder;
s6, putting the dry paste powder into a grinder for grinding, and screening by a vibrating screen;
s7, packaging the screened dry paste powder with a medicinal composite film, and bagging to obtain the finished product.
In the S2, 2kg of fresh acer truncatum leaves are cut into pieces, 20L of water is added, the mixture is boiled for 2 hours, filtered and repeated for three times.
And in the S3, concentrating the extract until the relative density is 1.12.
And in the step S4, auxiliary materials including maltodextrin, cyclodextrin and stevioside are added, wherein the addition amount of the auxiliary materials is 5%, 4% and 8% of the extract.
And in the step S5, the temperature of the dryer is 80 ℃, and the drying time is 45 min.
In the S6, the specification of the vibrating screen is 100 meshes.
Example 5: taking 50g of the acer truncatum leaf extract of the embodiment 4, adding 5g of soluble starch, 0.5g of beta-cyclodextrin, 1g of cane sugar and 200ml of water, stirring for dissolving, and drying in vacuum to obtain a product.
Experimental example 1: experiment of three-high reducing drinking effect
Subject: 200 cases of the patients with hypertension, hyperlipidemia or hyperglycemia are selected as experimental subjects according to clinical test results. Among them, 100 cases are male and 100 cases are female. All ages were between 30 and 55 years, and 200 subjects were randomly divided into 5 groups of 40, of which 20 were male and 20 were female. The judgment standards of hypertension, hyperlipidemia and hyperglycemia are subject to national regulation standards.
The experimental method comprises the following steps: the first, second, third, fourth and fifth groups take the tea granules of the embodiment 1-5 respectively, 2 times a day, 2g each time, and 3 months is a treatment course. During the experiment, other drugs were discontinued. Before the experiment, the special person records the blood pressure, blood fat and blood sugar values of each experimental object, and after three months, the blood pressure, blood fat and blood sugar values of each experimental object are counted again. If any value of the blood pressure, the blood fat or the blood sugar is reduced, the judgment is valid, otherwise, the judgment is invalid.
The results of the experiment are shown in table 1 below:
TABLE 1 Experimental results of drinking effect
Group of Number of effective persons High efficiency Number of invalid persons Inefficiency of
First group 34 85% 6 15%
Second group 31 78% 9 22%
Third group 35 88% 5 12%
Fourth group 34 85% 6 15%
Fifth group 33 83% 7 17%
And (4) analyzing results: as can be seen from Table 1, the obtained tea granule has the health-care functions of obviously reducing blood fat, blood pressure and blood sugar. Different experimental methods have influence on the effect of the tea granules, probably because different auxiliary materials have influence on the absorption capacity of effective substances in the acer truncatum bunge leaf extract.
Experimental example 2: effect on sleep in mice with threshold dose of sodium pentobarbital
SPF level Kunming mice, male and female, were divided into 3 groups at random according to body weight, each group containing 10 animals, namely model control group, acer truncatum leaf tea granule group (acer truncatum leaf tea granule prepared in example 1), and positive control group (sulbactam). The test substance or 0.5% CMC was administered to each group by gavage for 3 consecutive days 1 time per day. Pentobarbital sodium normal saline solution is injected intraperitoneally at 65mg/kg for 1h after the last administration except for a blank control group. And then observing the turning reflection of the animal, taking the disappearance of the turning reflection for more than 1min as sleep, taking the time of first entering the sleep as a sleep latency, and taking the sleep duration as the sum of multiple times of sleep time. If the user does not go into the sleep or goes into the sleep again within 1h, the test is ended. The results are shown in Table 2.
TABLE 2 Effect on sleep in threshold dose pentobarbital sodium mice
Figure BDA0002159455240000061
Comparison with model groups: p <0.05, P <0.01
The results show that the mice can enter a sleep state marked by disappearance of the righting reflex after intraperitoneal injection of a threshold dose of sodium pentobarbital.
The experimental result shows that the acer truncatum leaf tea granules can effectively shorten the sleep latency of animals, prolong the sleep time and have the effect of promoting sleep.
Experimental example 3: anti-aging test
The evaluation of the anti-aging effect of the acer truncatum leaf tea granules prepared in the examples 1 to 5 comprises the following specific test methods: 10 volunteers are selected from each experimental group, and the patients with age of 35-55 years have aging phenomena of relaxation, roughness, dullness, wrinkle deepening and increasing and the like; the application method comprises respectively taking the first, second, third, fourth and fifth groups
The tea granules of example 1-example 5 are taken 2 times a day, 2g each time, 1 month is a treatment course, and license plates are filed before and after the experiment. Comparing the photographs of day 0 and 1 month and asking the volunteers for a feeling of use in which facial skin became remarkably tight, elastic, wrinkle-reduced was significant; the facial skin becomes remarkably tight, the elasticity is increased, and wrinkles are reduced; the facial skin was not improved and was not effective. The specific test results are shown in table 3.
TABLE 3 results of the anti-aging test
Figure BDA0002159455240000062
Figure BDA0002159455240000071
From the results of table 3, it can be seen that:
the acer truncatum leaf tea granules prepared in the examples 1 to 5 have good anti-aging effect.
Experimental example 4: influence of the tea granules on defecation of constipation model mice
40 Kunming mice are divided into 4 groups according to weight, namely a normal control group (0.5 percent of tragacanth gum), a model control group (0.5 percent of tragacanth gum), a positive control group (rhubarb) and a acer truncatum leaf tea granule group (formula in example 1). Except for the normal control group, the constipation model is reproduced by reserpine and thyroxine after gastric lavage for 7 days; the test suspension was gavaged on day 5, 1 time daily for 3 consecutive days. Mice were placed on filter paper after the last dose and the time to first bowel movement and the number of bowel movements within 5h were recorded and the results are shown in table 4.
TABLE 4 Effect of electuary on defecation of Constipation model mice
Group of Dosage form First defecation time(s) Number of defecation granules (granules) 5h
Normal control —— 14.4±8.5** 15.7±5.8**
Model comparison —— 110.3±41.2 9.2±3.5
Positive control (rhubarb) 0.4g/kg 32.3±12.1** 17.2±6.8**
Acer truncatum leaf tea granule 0.4g/kg 52.3±14.6* 13.1±3.9**
P <0.05, P <0.01, compared to model control
The experimental results in table 4 show that the acer truncatum tea granules can effectively improve constipation.
Experimental example 5: the tea electuary has the effect of reducing weight
The tea infusion prepared in examples 1-5 was administered to 100kg-125kg of individuals, each of which had 50 trials, 25 men and 25 women. The effect was observed 30 days after 2 times a day with 2g of water. The effects produced after use are shown in table 5.
Figure BDA0002159455240000072
Figure BDA0002159455240000081
The experimental results in table 5 show that the acer truncatum leaf tea granules have good weight-losing effect on obese people.
The foregoing embodiments are merely illustrative of the principles and utilities of the present invention and are not intended to limit the invention. Any person skilled in the art can modify or change the above-mentioned embodiments without departing from the spirit and scope of the present invention. Accordingly, it is intended that all equivalent modifications or changes which can be made by those skilled in the art without departing from the spirit and technical spirit of the present invention be covered by the claims of the present invention.

Claims (8)

1. The preparation method of the acer truncatum leaf tea granules is characterized by comprising the following steps:
s1, preparing raw materials of acer truncatum leaves, a cosolvent, a flavoring agent and a sweetening agent;
s2, putting the acer truncatum leaves into an extraction tank, adding water, heating and decocting, and filtering repeatedly for three times to obtain filtrate;
s3, pumping the filtrate into a concentration tank through a liquid pump, and concentrating to obtain an extract;
s4, adding auxiliary materials into the extract, and stirring and uniformly mixing in a stirrer;
s5, putting the mixture into a dryer, and drying to obtain dry paste powder;
s6, putting the dry paste powder into a grinder for grinding, and screening by a vibrating screen;
s7, packaging the screened dry paste powder with a medicinal composite film, and bagging to obtain the finished product.
2. The preparation method of the acer truncatum leaf tea granules as claimed in claim 1, which is characterized by comprising the following steps: and in the S2, water is added, the water is 5-40 times of the acer truncatum leaves, the mixture is heated and decocted for 0.5-5 hours, then the water is added, the mixture is heated and decocted for 0.5-5 hours, and the mixture is further heated and decocted for 0.5-5 hours.
3. The preparation method of the acer truncatum leaf tea granules as claimed in claim 1, which is characterized by comprising the following steps: and in the S3, concentrating the extract until the relative density is 1.00-1.20.
4. The preparation method of the acer truncatum leaf tea granules as claimed in claim 1, which is characterized by comprising the following steps: in the S4, the auxiliary materials are cosolvent, flavoring agent or sweetener, and the adding amount is 0.05-200%, 0-5% and 0-10% of the extract.
5. The cosolvent according to claim 4, comprising one or more of sodium benzoate, citric acid, calcium lactate, maltodextrin, soluble starch, and tween 80; the flavoring agent comprises one or more of peppermint oil, essence and beta-cyclodextrin; the sweetener comprises one or more of stevioside, sucrose, honey, fructose, glycyrrhizin, aspartame and saccharin sodium.
6. The preparation method of the acer truncatum leaf tea granules as claimed in claim 1, which is characterized by comprising the following steps: and in the step S5, the temperature of the dryer is 40-100 ℃, and the drying time is 20-100 min.
7. The preparation method of the acer truncatum leaf tea granules as claimed in claim 1, which is characterized by comprising the following steps: in the S6, the specification of the vibrating screen is 80-120 meshes.
8. According to claims 1-8, the tea granule has the effects of reducing high blood pressure, high blood lipid, helping sleep, losing weight, resisting aging and improving constipation.
CN201910727611.9A 2019-08-07 2019-08-07 Preparation method of acer truncatum leaf tea granules Pending CN112336756A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN201910727611.9A CN112336756A (en) 2019-08-07 2019-08-07 Preparation method of acer truncatum leaf tea granules
PCT/CN2020/080048 WO2021022813A1 (en) 2019-08-07 2020-03-18 Method for preparing acer truncatum leaf tea granule

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910727611.9A CN112336756A (en) 2019-08-07 2019-08-07 Preparation method of acer truncatum leaf tea granules

Publications (1)

Publication Number Publication Date
CN112336756A true CN112336756A (en) 2021-02-09

Family

ID=74367334

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910727611.9A Pending CN112336756A (en) 2019-08-07 2019-08-07 Preparation method of acer truncatum leaf tea granules

Country Status (2)

Country Link
CN (1) CN112336756A (en)
WO (1) WO2021022813A1 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1537628A (en) * 2003-10-22 2004-10-20 云南威达元宝枫产业开发有限公司 Purpleblow maple lozenge for health-care,and its prepn. method

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1227999C (en) * 2003-10-22 2005-11-23 云南威达元宝枫产业开发有限公司 Health-care instant purpleblow maple granule preparaction , and its prepn. method
CN106804844A (en) * 2017-01-20 2017-06-09 谭正杰 Acer truncatum tea drink formula and preparation method thereof
CN107439763B (en) * 2017-09-08 2020-11-03 无锡新禾创工食品科技有限公司 Acer truncatum tea beverage and preparation method thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1537628A (en) * 2003-10-22 2004-10-20 云南威达元宝枫产业开发有限公司 Purpleblow maple lozenge for health-care,and its prepn. method

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
汪萌等: "元宝枫的药用植物化学成分及药理作用研究进展", 《黑龙江医药》 *

Also Published As

Publication number Publication date
WO2021022813A1 (en) 2021-02-11

Similar Documents

Publication Publication Date Title
CN106075130A (en) A kind of Health-protection traditional Chinese medicinal preparation for fat-eliminating slimming
CN101502627B (en) Chinese medicine health product preparation for preventing and treating alcoholic liver disease and preparation method thereof
CN103007146B (en) Healthcare nutrition powder for enhancing memory ability
CN107397208B (en) Functional food containing fish glue as main component and its use
US10111451B2 (en) Food, beverage or pharmaceutical composition containing fermented eastern prickly pear and a preparation method therefor
CN105707598A (en) Plant drink for dispelling alcohol effects and preparation method thereof
CN109731066A (en) A kind of Chinese medicine composition and its application, health food with antifatigue effect
CN108813501A (en) With the relieving cough and reducing sputum health honey paste relievingd asthma and adjust function of human body of clearing heat and moistening lung
CN111567797A (en) Compound jasmine tea chewable tablet and preparation method thereof
CN104206586A (en) Fragrant-type purslane health-caring tea and preparation method thereof
CN112336756A (en) Preparation method of acer truncatum leaf tea granules
CN104799292A (en) Intestine-moistening and bowels-relaxing food and preparation method thereof
CN108403933A (en) A kind of time of childbirth meal is stimulated the secretion of milk qi-blood tonifying Chinese medicine composition of rehabilitation and preparation method thereof
CN114651968A (en) Hangover alleviating composition formula and preparation method thereof
CN103652906B (en) A kind of nourishing Yin and promoting production of body fluid radix rehmanniae recen chewable tablets and preparation method
CN107950946B (en) Instant licorice leisure food and preparation method thereof
CN112450396A (en) Clausena lansium compound composition and preparation method and application thereof
CN102485263B (en) Medicinal composition for treating chronic cough of children and its preparation method
CN105535587A (en) Traditional Chinese medicinal preparation for treating heart and kidney disharmony type palpitation and insomnia and preparation method of traditional Chinese medicinal preparation
CN101361767A (en) Medicine for relieving cough, eliminating sputum, relieving dyspepsia, promoting blood and dissipating blood stasis and preparation method thereof
CN108813500A (en) With tonifying middle-Jiao and Qi, nourishing blood and tranquilization and the health honey paste for adjusting function of human body
KR102517826B1 (en) Manufacturing method of improving composition the health and development of growing children with excellent palatability
CN115607629B (en) Traditional Chinese medicine composition with liver protecting and alcohol effect dispelling functions and preparation method thereof
CN102935198B (en) Food or traditional Chinese medicine for regulating spleen, stomach and intestine functions, sobering up and protecting liver and application of food or traditional Chinese medicine for regulating spleen, stomach and intestine functions, sobering up and protecting liver
CN102631486B (en) Health care composition

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20210209